Epilepsy Clinical Trials

Trials for someone you care about with epilepsy.

Brain & Nervous System

Recruiting Drug Device Behavioral Older adults Healthy volunteers

3 trials

Only a few results?

Someone at Concord can look with you.

Testing XEN1101 against a placebo for primary generalized tonic-clonic seizures

Explore this study →

There are 3 groups in this study. Groups A and B receive XEN1101. Group C, the placebo group, receives Placebo.

Sites in Lethbridge, London and 2 more cities

Phase 3
3 groups
Sites in Lethbridge, Vancouver and 2 more cities
Recruiting

Official title: A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

Primary Generalized Tonic-Clonic Seizures · Xenon Pharmaceuticals Inc.

Testing Lemborexant against a placebo for epilepsy

Explore this study →

There are 2 groups in this study. Group A, the placebo group, receives Placebo, together with one or more of: Lemborexant. Group B, the comparison group, receives one or more of: Lemborexant and Placebo.

One site, in Winnipeg

Phase 3
2 groups
One site, in Winnipeg
Recruiting

Official title: Lemborexant Treatment of Insomnia Linked to Epilepsy

Epilepsy · University of Manitoba

Testing Ferumoxytol for temporal lobe epilepsy

Explore this study →

Everyone in this study is in one group and receives Ferumoxytol.

One site, in Edmonton

Phase 2
1 group
One site, in Edmonton
Recruiting

Official title: Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy

Epilepsy, Temporal Lobe · University of Alberta

Get them matched to the best-fit trials

Answer a few questions and we'll find the closest matches for epilepsy.

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Get notified when a matching trial opens

We'll watch for Epilepsy trials near you.

← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.